Self-Emulsifying Formulation for Lipophilic Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current self-emulsifying drug delivery systems (SEDDS) for lipophilic compounds like cannabinoids face challenges such as poor oral bioavailability, high variability in drug absorption, and patient compliance due to issues like drug precipitation and hepatic first-pass metabolism, as well as difficulties in formulation and manufacturing.
Innovation Solution
A self-emulsifying formulation comprising a lipophilic compound, at least 10 wt% oil, a surfactant, and a structurant, designed to spontaneously form nanoemulsions in aqueous diluents, enhancing solubility and bioavailability while minimizing mucosal irritation and hepatic first-pass effect.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lipophilic compounds are administered orally, then the absorption rate is controlled by dissolution, but oral bioavailability is poor due to high lipophilicity
Solution Approach 1:
The patent changes the physical and chemical parameters of the lipophilic compound by incorporating it into a self-emulsifying formulation containing surfactants and co-solvents. This transformation converts the compound from a poorly water-soluble state to a state that forms fine emulsion droplets upon contact with gastrointestinal fluids, thereby improving dissolution rate and oral bioavailability without requiring complex manufacturing processes
Solution Approach 2:
The patent introduces self-emulsifying agents (surfactants and co-solvents) as intermediary substances that facilitate the dissolution and absorption of lipophilic compounds. These agents act as mediators between the lipophilic drug and the aqueous gastrointestinal environment, enabling improved bioavailability while maintaining formulation simplicity
2Reliability
If self-emulsifying formulations are used to improve bioavailability, then solubility is enhanced, but drug precipitation may occur
Solution Approach 1:
The patent creates a composite self-emulsifying formulation that integrates the lipophilic compound with surfactants and co-solvents in specific ratios. This composite system ensures that the drug remains solubilized within the emulsion matrix, preventing precipitation while maintaining enhanced solubility. The composite nature provides both the solubility enhancement and the stability needed to prevent drug crystallization
Solution Approach 2:
The formulation is designed with sufficient surfactant and co-solvent concentrations beforehand to prevent drug precipitation before it can occur during administration. The self-emulsifying agents are pre-positioned in the formulation at levels that ensure continuous solubilization of the lipophilic compound throughout the gastrointestinal tract, cushioning against potential precipitation events
3Reliability
If lipid-based formulations are used to improve oral bioavailability, then absorption is enhanced, but patient compliance is low due to liquid form and bitter taste
Solution Approach 1:
The patent changes the physical state parameter of the formulation by using semi-solid or viscous liquid bases instead of free-flowing liquids. This parameter change allows the formulation to be easily encapsulated in soft gelatin capsules, transforming it into a convenient oral dosage form that masks the bitter taste and improves patient compliance while maintaining the lipid-based mechanism for enhanced bioavailability
4Reliability
If conventional SEDDS are used, then emulsification is achieved, but manufacturing and formulation are difficult
Solution Approach 1:
The patent employs self-emulsifying formulations that automatically form fine emulsion droplets upon contact with gastrointestinal fluids without requiring external emulsification equipment or complex processing. The formulation contains self-emulsifying agents that perform the emulsification function autonomously, eliminating the need for specialized manufacturing equipment and simplifying the formulation process while ensuring reliable emulsification in the body
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation improves oral bioavailability and patient compliance by stabilizing lipophilic compounds, reducing dosing frequency, and maintaining therapeutic efficacy with enhanced pharmacokinetic profiles and reduced adverse effects.
Implementation Method 1
A self-emulsifying formulation comprising a lipophilic compound, at least 10 wt% oil, a surfactant, and a structurant, designed to spontaneously form nanoemulsions in aqueous diluents
Implementation Method 2
A self-emulsifying formulation comprising a lipophilic compound, at least 10 wt% oil, a surfactant, and a structurant
Data Source
AI summary
The present disclosure provides self-emulsifying drug delivery systems for delivery of lipophilic compounds, compositions, kits and unit dosage forms thereof, as well as processes for their preparation.